ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, A.
Right arrow Articles by Akiyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, A.
Right arrow Articles by Akiyama, K.
Eur Respir J 2005; 26:1069-1073
Copyright ©ERS Journals Ltd 2005

Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis

A. Higashi1,2, N. Higashi1,2, T. Tsuburai1, Y. Takeuchi1, M. Taniguchi1, H. Mita1, A. Saito1, K. Takatori3, K. Arimura2 and K. Akiyama1

1 Clinical Research Center, National Sagamihara Hospital, Sagamihara, 2 Dept of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Science, Kagoshima, and 3 Division of Microbiology, National Institute of Health Sciences, Tokyo, Japan.

CORRESPONDENCE: N. Higashi, Dept of Allergy, Kagoshima Univeristy Graduate School of Medical and Dental Science, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan. Fax: 81 992657164. E-mail: Noritaka.Higashi{at}ki.se

Keywords: Extrinsic allergic alveolitis, 8-iso prostaglandin F2{alpha}, prostaglandin D2, surfactant protein D

Received: September 10, 2004
Accepted August 15, 2005


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The pathophysiology of extrinsic allergic alveolitis (EAA) involves oxidative lung damage as well as interstitial and alveolar inflammation. Macrophages and mast cells are inflammatory components of EAA that produce both leukotrienes (LTs) and prostaglandin D2 (PGD2). In addition, PGD2 is also produced by the free-radical-catalysed peroxidation of arachidonic acid during oxidative stress. Urinary 8-iso prostaglandin F2{alpha} (8-isoPGF2{alpha}) and serum surfactant protein D (SP-D) are considered appropriate biomarkers of oxidative stress and interstitial lung disease activity, respectively. The present study aimed to assess the association of these biomarkers with the pathophysiology of EAA.

Two cases of acute EAA caused by the inhalation of fungi spores were reported. Eight asthmatic patients and six healthy control subjects were also enrolled in the current study.

The serum SP-D and urinary eicosanoid (LTE4, PGD2 metabolite (9{alpha},11ßPGF2), 8-isoPGF2{alpha}) concentrations markedly increased during the acute exacerbation phase. These concentrations decreased following corticosteroid therapy in the EAA patients. There was a significant correlation between serum SP-D and urinary 9{alpha},11ßPGF2 concentrations in the EAA patients.

In conclusion, although the present study proposes that serum surfactant protein-D and urinary eicosanoids are new biomarkers involved in the various immunological responses in extrinsic allergic alveolitis, further large-scale studies are needed to investigate the role of these compounds, not just as biomarkers, but also as biological potentiators of extrinsic allergic alveolitis.

Acute extrinsic allergic alveolitis (EAA) is characterised by oxidative lung damage 1. During oxidative stress, prostaglandin D2 (PGD2) is nonenzymatically produced by the free-radical-catalysed peroxidation of arachidonic acid (isoprostane pathway) 2. Briefly, isoprostanes are a unique series of PG-like compounds formed by the random oxidation of tissue phospholipids by oxygen radicals 2. Thus, isoprostanes contain racemic mixtures of E-, D-, F-type and thromboxane-type prostane rings 3, 4. The racemic D-ring isoprostane (12-isoPGD2) subsequently undergoes rapid epimerisation to racemic PGD2 2.

In contrast, alveolar macrophages and mast cells produce cysteinyl-leukotrienes (CysLTs) and cyclooxygenase-dependent PGD2 5, 6. Alveolar macrophages play a key role in acute EAA 7. There is also a persistent increase in the number of alveolar mast cells in EAA patients 8. EAA is categorised as a T-helper1-type disease and interferon (IFN)-{gamma} plays a pivotal role in granuloma formation in EAA 7. Interestingly, mast cells, which express the Fc{gamma} receptor I after incubation with IFN-{gamma}, can produce PGD2 and CysLTs even in response to immunoglobulin (Ig)G stimulation 9.

Urinary leukotriene E4 (LTE4) is now considered to be the most reliable analytical parameter for monitoring the endogenous synthesis of CysLTs 10, 11. Similarly, urinary 9{alpha},11ß prostaglandin F2 (9{alpha},11ßPGF2) is a relatively stable PGD2 metabolite and an appropriate indicator of mast cell activation 5. Of the isoprostanes, 8-iso prostaglandin F2{alpha} (8-isoPGF2{alpha}) is the best-characterised isomer and urinary 8-isoPGF2{alpha} is considered the most accurate indicator of oxidant stress 2. Taking this into account, it was hypothesised that patients with acute EAA show increased concentrations of urinary eicosanoids (CysLTs, 9{alpha},11ßPGF2 and 8-isoPGF2{alpha}).

Surfactant protein D (SP-D), which is produced by alveolar type II and Clara cells 12, is an important regulatory molecule in both pulmonary surfactant homeostasis and first-line defence mechanisms against microbial or allergen challenges 13. Krebs von den Lungen-6 (KL-6) is also produced by alveolar type II cells 14. The measurements of serum SP-D and KL-6 concentrations contribute to the early diagnosis of interstitial lung disease (ILD) 12, 14. EAA is an acute ILD 7. Previous studies have demonstrated significant increases in SP-A and KL-6 concentrations in the bronchoalveolar lavage fluid (BALF) of acute EAA patients 15. Although plasma SP-D concentration is one of the most appropriate prognostic parameters of acute respiratory distress syndrome (ARDS) 16, knowledge of the serum SP-D profile of acute EAA patients is limited 17.

The present study aims to assess the association of these biomarkers with the pathophysiology of EAA.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Case reports
Case 1
A 61-yr-old, nonsmoking female suffered from summer-type EAA caused by Trichosporon asahii, the most prevalent cause of EAA in Japan 18. Cell counts revealed that 58.9% of total BALF cells were lymphocytes and the CD4/CD8 ratio of lymphocyte surface markers was 0.6. In addition, transbronchial lung biopsy specimens exhibited lymphocytic alveolitis with granulomas. The subject was diagnosed positive for precipitin to T. asahii by double immunodiffusion analysis. The positive findings were confirmed during a provocation test, following which the patient was allowed to return home.

Case 2
A 48-yr-old, nonsmoking female suffered from occupational EAA caused by Aspergillus niger, predominantly isolated from house dust in her workplace (a linen room). In addition to being strongly positive for precipitins to both house dust and A. niger extract, determined by double immunodiffusion analysis, the patient was also positive for a serum-specific IgG antibody against A. niger (10.8 mg·dL–1). High-resolution computed tomography of the patient's chest revealed supportive radiographic findings 7. The results from both cases are shown in table 1Go.


View this table:
[in this window]
[in a new window]
  		Table. 1— Serum Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) concentrations on admission

 
Both EAA patients fulfilled the American-European Consensus Conference criteria for ARDS (table 1Go) 19. Intensive corticosteroid treatment (i.v. administration of 1,000 mg·day–1 methylprednisolone for 3 days, followed by oral administration of 0.5 mg·kg–1 prednisone) was tapered over the 7-week period, resulting in gradual improvements of both clinical symptoms and radiographic findings.

Control subjects
Eight (six female) stable asthmatic patients (mean age (range) 58 (33–73) yrs) were enrolled as diseased control subjects. Six (three female) healthy control subjects (44 (29–58) yrs) were also enrolled for comparative analysis of urinary eicosanoid data. All the subjects were nonsmokers. Permission to conduct the study was obtained from the Ethics Committee of the National Sagamihara Hospital (Japan) and all participating subjects gave informed consent.

Measurements
Serum and spot urine samples were collected between 09:00–11:00 h. In the case of subjects with acute EAA, urine samples were collected on admission and following therapy. The samples were analysed for KL-6, SP-D and eicosanoid concentrations by methods previously described 10, 12, 17, 20. Double immunodiffusion analysis of precipitating antibodies against 18 different fungal species was performed according to the Ouchterlony method. A specific IgG antibody against A. niger was performed utilising the liquid-phase immunoassay AlaSTAT microplate system (Diagnostic Products Corporation, Los Angeles, USA).

Data analysis
Serum and urinary data were expressed as mean and median, respectively. Relationships were analysed using Spearman's rank correlation test. A p-value <0.05 was regarded as statistically significant.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Serum KL-6 and SP-D concentrations were markedly higher in the acute EAA patients than in the eight asthmatic patients (table 1Go). As shown in figure 1Go, urinary eicosanoid concentrations in the acute EAA patients (LTE4: 420 and 185 pg·mg–1-creatinine; 9{alpha},11ßPGF2: 658 and 382 pg·mg–1-creatinine; 8-isoPGF2{alpha}: 393 and 537 pg·mg–1-creatinine) were markedly higher than in the healthy control subjects (LTE4: 45 pg·mg–1-creatinine; 9{alpha},11ßPGF2: 43 pg·mg–1-creatinine; 8-isoPGF2{alpha}: 187 pg·mg–1-creatinine). Median values of urinary LTE4, 9{alpha},11ßPGF2 and 8-isoPGF2 concentrations in the asthmatic patients were 55, 79 and 235 pg·mg–1-creatinine, respectively. The serum SP-D, KL-6 and urinary eicosanoid concentrations decreased following corticosteroid therapy in the EAA patients (figs 1Go and 2Go). There was a significant correlation between serum SP-D and urinary 9{alpha},11ßPGF2 concentrations in the EAA patients (p<0.05, rs = 1; fig. 2Go).



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 1— a) Urinary leukotriene E4 (LTE4), b) 9{alpha},11ß prostaglandin F2 (9{alpha},11ßPGF2), and c) 8-iso prostaglandin F2{alpha} (8-isoPGF2{alpha}) concentrations in the extrinsic allergic alveolitis patients. BA: asthmatic patients; HC: healthy control subjects. Horizontal bars indicate median values.

 


View larger version (11K):
[in this window]
[in a new window]
  		Fig. 2— A significant correlation between serum surfactant protein D (SP-D) and urinary 9{alpha},11ß prostaglandin F2 (9{alpha},11ßPGF2) concentration was found in the extrinsic allergic alveolitis patients. rs = 1; p<0.05.

 

   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The present authors demonstrated, for the first time, that acute EAA is characterised by eicosanoid overproduction. Although increased urinary LTE4 concentration has been reported in patients with ARDS 21, to the current authors' knowledge this is the first report demonstrating a PGD2 overproduction in patients with ARDS or even acute EAA. The CysLT and PGD2 overproduction may well be associated with the increased cyclooxygenase activity of both alveolar macrophages 6 and mast cells 5. However, the higher urinary 9{alpha},11ßPGF2 concentrations in EAA patients are mainly considered to be a reflection of mast cell activation 5, 22. Interestingly, mast cells activated by aggregated IgG, following IFN-{gamma}-induced upregulation of Fc{gamma} receptor I, can produce both PGD2 and CysLTs 9, which is consistent with the pathophysiology of EAA.

8-isoPGF2{alpha} is an accurate biomarker of oxidative stress in vivo 2. The present study demonstrated that urinary 8-isoPGF2{alpha} concentration is increased in acute EAA patients, suggesting a central role for oxidant stress in the pathogenesis of acute EAA. The isoprostane pathway also contributes to the PGD2 overproduction in acute EAA 2, although the current approach was unable to ascertain its relative contribution to PGD2 production. It has recently been discovered that isoprostanes containing D- or E-type prostane rings are excreted into the urine as conjugates with N-acetyl cysteine sulfoxide, suggesting that these metabolites may be used as biomarkers to estimate whole-body production of D- or E-type isoprostanes 23. Future experiments using this methodology will hopefully provide even more answers.

Increased 8-isoPGF2{alpha} concentrations have been reported in the breath condensate of patients with ARDS 24, ILD 25 and asthma 26. Recently, Wood et al. 27 demonstrated that despite high variability, sputum 8-isoPGF2{alpha} concentrations were significantly increased in patients with severe persistent asthma. The present study also demonstrated similar findings in that the two asthmatic patients with extremely high urinary 8-isoPGF2{alpha} concentrations (458 and 525 pg·mg–1-creatinine, respectively) were characterised by severe persistent asthma and hypereosinophilia (11.2 and 17.2%, respectively).

These eicosanoids are also known to possess various other biological activities, such as being potent constrictors of pulmonary vascular smooth muscle and causing plasma exudation 4–6. Although the full extent of the biological activity of the eicosanoids in acute EAA remains to be determined, the various components of the eicosanoid metabolic pathways may become therapeutic targets in acute EAA.

Consistent with a previous case report by Tanaka et al. 17, serum SP-D concentrations in the acute EAA patients were markedly increased. In contrast, serum SP-D concentrations in the asthmatic patients were low, which is in accordance with data by Koopmans et al. 28 Interestingly, the serum SP-D concentrations subsequently decreased and showed a significant correlation with urinary 9{alpha},11ßPGF2 concentrations in the EAA patients. Serum SP-D is a biomarker of ILD activity 12 and SP-D plays a protective role in pulmonary inflammation 13. PGD2 and its metabolite, 15-d-PGJ2, have the potential to serve as downregulators of lung injury induced by bleomycin 29. Taken together, these findings suggest that both SP-D and PGD2 appear to be important regulatory factors in the pathophysiology of EAA.

In conclusion, the present study proposes that serum surfactant protein D and urinary eicosanoids are new biomarkers involved in various immunological responses in extrinsic allergic alveolitis. Further large-scale studies are needed to investigate the role of these compounds, not just as biomarkers, but also as potentiators of extrinsic allergic alveolitis.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Calhoun WJ. Enhanced reactive oxygen species metabolism of air space cells in hypersensitivity pneumonitis. J Lab Clin Med 1991;117:443–452.[Medline] [Order article via Infotrieve]
  2. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383–9387.[Abstract/Free Full Text]
  3. Morrow JD, Chen Y, Brame CJ, et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 1999;31:117–139.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  4. Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002;166:S25–S30.
  5. Dahlen SE, Kumlin M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 2004;59:453–455.[Free Full Text]
  6. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111: : Suppl. 1 S18–S34.[CrossRef][Medline] [Order article via Infotrieve]
  7. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001;108:661–670.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  8. Laviolette M, Cormier Y, Loiseau A, et al. Bronchoalveolar mast cells in normal farmers and subjects with farmer's lung. Diagnostic, prognostic, and physiologic significance. Am Rev Respir Dis 1991;144:855–860.[Web of Science][Medline] [Order article via Infotrieve]
  9. Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin Immunol 2004;110:172–180.[CrossRef][Medline] [Order article via Infotrieve]
  10. Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 2002;32:1484–1490.[Medline] [Order article via Infotrieve]
  11. Kumlin M. Measurements of leukotrienes in the urine: strategies and applications. Allergy 1997;52:124–135.[Web of Science][Medline] [Order article via Infotrieve]
  12. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860–1866.[Abstract]
  13. Ikegami M, Hull WM, Yoshida M, Wert SE, Whitsett JA. SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol 2001;281:L697–L703.[Abstract/Free Full Text]
  14. Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637–642.[Web of Science][Medline] [Order article via Infotrieve]
  15. Hamm H, Luhrs J, Guzman y Rotaeche J, Costabel U, Fabel H, Bartsch W. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994;106:1766–1770.[Abstract/Free Full Text]
  16. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003;58:983–988.[Abstract/Free Full Text]
  17. Tanaka H, Sugawara H, Saikai T, Tsunematsu K, Takahashi H, Abe S. Mushroom worker's lung caused by spores of Hypsizigus marmoreus (Bunashimeji): elevated serum surfactant protein D levels. Chest 2000;118:1506–1509.[Abstract/Free Full Text]
  18. Matsunaga Y, Usui Y, Yoshizawa Y. TA-19, a novel protein antigen of Trichosporon asahii, in summer-type hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;167:991–998.[Abstract/Free Full Text]
  19. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818–824.[Abstract]
  20. Morrow JD, Zackert WE, Yang JP, et al. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 1999;269:326–331.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  21. Bernard GR, Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991;144:263–267.[Web of Science][Medline] [Order article via Infotrieve]
  22. Cai Y, Bjermer L, Halstensen TS. Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma. Am J Respir Cell Mol Biol 2003;29:683–693.[Abstract/Free Full Text]
  23. Milne GL, Gao L, Porta A, Zanoni G, Vidari G, Morrow JD. Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A2t-isoprostane in vivo. J Biol Chem 2005;280:25178–25184.[Abstract/Free Full Text]
  24. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998;114:1653–1659.[Abstract/Free Full Text]
  25. Montuschi P, Ciabattoni G, Paredi P, et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998;158:1524–1527.[Abstract/Free Full Text]
  26. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216–220.[Abstract/Free Full Text]
  27. Wood LG, Garg ML, Simpson JL, et al. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 2005;171:426–430.[Abstract/Free Full Text]
  28. Koopmans JG, van der Zee JS, Krop EJ, Lopuhaa CE, Jansen HM, Batenburg JJ. Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy 2004;34:1827–1833.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  29. Ando M, Murakami Y, Kojima F, et al. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Am J Respir Cell Mol Biol 2003;28:582–591.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, A.
Right arrow Articles by Akiyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, A.
Right arrow Articles by Akiyama, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS